Published in Ann Intern Med on April 03, 2012
Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst (2013) 8.75
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Overdiagnosis among women attending a population-based mammography screening program. Int J Cancer (2013) 3.02
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell (2012) 2.94
Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst (2015) 2.81
Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (2013) 2.25
Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time. Breast Cancer Res (2013) 2.11
Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Ann Intern Med (2013) 1.84
Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ (2015) 1.61
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. J Natl Cancer Inst (2015) 1.56
The cost of breast cancer screening in the Medicare population. JAMA Intern Med (2013) 1.53
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study. Br J Cancer (2013) 1.42
Citations of scientific results and conflicts of interest: the case of mammography screening. Evid Based Med (2013) 1.42
Overdiagnosis in breast cancer screening: time to tackle an underappreciated harm. Ann Intern Med (2012) 1.32
Overestimated lead times in cancer screening has led to substantial underestimation of overdiagnosis. Br J Cancer (2013) 1.26
Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees. Ann Intern Med (2013) 1.26
Benefits and harms of mammography screening. Breast Cancer Res (2015) 1.22
Setting a research agenda for medical overuse. BMJ (2015) 1.13
Mammography use among women ages 40-49 after the 2009 U.S. Preventive Services Task Force recommendation. J Gen Intern Med (2013) 1.12
Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer. PLoS One (2014) 1.04
Breast cancer screening: evidence of benefit depends on the method used. BMC Med (2012) 1.04
Breast cancer screening: the questions answered. Nat Rev Clin Oncol (2012) 1.02
Diagnosing overdiagnosis: conceptual challenges and suggested solutions. Eur J Epidemiol (2014) 1.00
The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries. Cancer (2013) 0.99
Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat (2013) 0.96
Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program. CMAJ (2013) 0.92
Lead-time models should not be used to estimate overdiagnosis in cancer screening. J Gen Intern Med (2014) 0.92
Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers. Evid Based Med (2012) 0.88
Higher incidence of premenopausal breast cancer in less developed countries; myth or truth? BMC Cancer (2014) 0.87
Were our estimates of overdiagnosis with mammography screening in the United States "based on faulty science"? Oncologist (2014) 0.87
Screening guidelines for non-AIDS defining cancers in HIV-infected individuals. Curr Opin Oncol (2013) 0.87
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.85
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers. BMC Cancer (2013) 0.84
The clinical breast exam: a skill that should not be abandoned. J Gen Intern Med (2013) 0.82
Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study. BMC Cancer (2013) 0.82
A comparison of the risks of in-breast recurrence after a diagnosis of dcis or early invasive breast cancer. Curr Oncol (2014) 0.81
A nation-wide multicenter retrospective study of the epidemiological, pathological and clinical characteristics of breast cancer in situ in Chinese women in 1999 - 2008. PLoS One (2013) 0.80
Is the tide turning against breast screening? Breast Cancer Res (2012) 0.80
Preventive health services implemented by family physicians in Portugal-a cross-sectional study based on two clinical scenarios. BMJ Open (2014) 0.80
Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women. J Med Internet Res (2015) 0.80
Four Principles to Consider Before Advising Women on Screening Mammography. J Womens Health (Larchmt) (2015) 0.79
Mammary cancer initiation and progression studied with magnetic resonance imaging. Breast Cancer Res (2014) 0.79
Impact of an educational intervention on provider knowledge, attitudes, and comfort level regarding counseling women ages 40-49 about breast cancer screening. J Multidiscip Healthc (2015) 0.78
The geographic distribution of mammography resources in Mississippi. Online J Public Health Inform (2014) 0.77
Inequalities in socioeconomic status and race and the odds of undergoing a mammogram in Brazil. Int J Equity Health (2016) 0.77
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.77
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.77
Pitfalls in accurate estimation of overdiagnosis: implications for screening policy and compliance. Breast Cancer Res (2013) 0.77
Can we negotiate with a tumor? PLoS One (2014) 0.76
Screening mammography: sparing the emperor's blushes. Cancer Med (2016) 0.75
Viewpoint: It is time to reconsider policy for population-based mammography screening. J Public Health Policy (2015) 0.75
Implementing a screening program for acromegaly in Latin America: necessity versus feasibility. Pituitary (2016) 0.75
Conditions for Valid Empirical Estimates of Cancer Overdiagnosis in Randomized Trials and Population Studies. Am J Epidemiol (2016) 0.75
Mammographic screening for breast cancer: Are the chickens coming home to roost? South Asian J Cancer (2013) 0.75
Mammography screening and women with symptomatic breast cancer. Nat Rev Clin Oncol (2013) 0.75
Overdiagnosis of Invasive Breast Cancer due to Mammography Screening. Ann Intern Med (2012) 0.75
Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesions. World J Radiol (2016) 0.75
Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014. Cancer (2016) 0.75
Missteps in Current Estimates of Cancer Overdiagnosis. Acad Radiol (2016) 0.75
Does screening mammography lead to overdiagnosis of invasive breast cancer? Am Fam Physician (2013) 0.75
The mythical concept and untoward consequences of a diagnosis of dysplastic nevus: an overdue tribute to A. Bernard Ackerman, MD. Dermatol Pract Concept (2015) 0.75
Enigmas, priorities and opportunities in cancer epidemiology. Eur J Epidemiol (2017) 0.75
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2005) 16.35
Cumulative association of five genetic variants with prostate cancer. N Engl J Med (2008) 15.34
Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med (2011) 13.30
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med (2002) 10.64
Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med (2014) 10.06
Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med (2010) 8.71
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst (2008) 8.62
Natural history of early, localized prostate cancer. JAMA (2004) 7.44
The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 6.61
[In Process Citation]. Tidsskr Nor Laegeforen (2015) 6.35
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Long-term colorectal-cancer mortality after adenoma removal. N Engl J Med (2014) 5.05
Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP. J Natl Cancer Inst (2007) 4.85
Non-communicable diseases in sub-Saharan Africa: what we know now. Int J Epidemiol (2011) 4.74
Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ (2012) 4.05
Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84
[More harm than benefit - how much should the patients know?]. Tidsskr Nor Laegeforen (2017) 3.82
Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ (2004) 3.67
Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst (2008) 3.55
Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol (2011) 3.45
The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer (2007) 3.44
A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst (2003) 3.29
Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst (2005) 3.19
Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12. Nat Genet (2008) 3.14
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell (2012) 2.94
Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol (2013) 2.84
Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort study. Lancet (2002) 2.72
Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol (2012) 2.62
Average energy intake among pregnant women carrying a boy compared with a girl. BMJ (2003) 2.55
Genome-wide association scans for secondary traits using case-control samples. Genet Epidemiol (2009) 2.55
Prostate-specific antigen levels as a predictor of lethal prostate cancer. J Natl Cancer Inst (2007) 2.49
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics (2010) 2.40
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Sector resection with or without postoperative radiotherapy for stage I breast cancer: 20-year results of a randomized trial. J Clin Oncol (2014) 2.35
Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol (2012) 2.28
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst (2006) 2.23
The socioeconomic gradient in the incidence of stroke: a prospective study in middle-aged women in Sweden. Stroke (2006) 2.23
Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol (2002) 2.19
Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18
Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res (2011) 2.11
Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst (2007) 2.08
Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies. BMJ (2014) 2.06
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A (2011) 2.03
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 1.99
[What should non-inferiority studies be called in Norwegian?]. Tidsskr Nor Laegeforen (2014) 1.98
A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.97
The capsule and colorectal-cancer screening--the crux of the matter. N Engl J Med (2009) 1.95
Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res (2004) 1.91
Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst (2008) 1.90
Non-communicable diseases in sub-Saharan Africa: the case for cohort studies. PLoS Med (2010) 1.88
Atopy and risk of non-Hodgkin lymphoma. J Natl Cancer Inst (2007) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev (2004) 1.82
Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80
Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst (2012) 1.79
Multiple myeloma: a review of the epidemiologic literature. Int J Cancer (2007) 1.78
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2008) 1.77
Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77
Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst (2011) 1.75
Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst (2006) 1.68
Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol (2007) 1.68
Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev (2005) 1.66
Ultraviolet exposure and mortality among women in Sweden. Cancer Epidemiol Biomarkers Prev (2011) 1.61
Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int J Cancer (2012) 1.61
Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol (2003) 1.59
Taxonomy of breast cancer based on normal cell phenotype predicts outcome. J Clin Invest (2014) 1.58
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58
Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. BMJ (2008) 1.57
Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat (2010) 1.56
Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev (2010) 1.56
Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst (2005) 1.55
Colonoscopy as a triage screening test. N Engl J Med (2012) 1.55
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study. Cancer Epidemiol Biomarkers Prev (2002) 1.54
Optimizing the design of web-based questionnaires--experience from a population-based study among 50,000 women. Eur J Epidemiol (2007) 1.51
Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clin Cancer Res (2009) 1.51
Gene × physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry. PLoS Genet (2013) 1.51
Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst (2012) 1.50
Treatment-related amenorrhea and sexual functioning in young breast cancer survivors. Cancer (2014) 1.48
Which tool is best for colorectal cancer screening? BMJ (2010) 1.47
Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat (2012) 1.46
Consumption of fish products across the lifespan and prostate cancer risk. PLoS One (2013) 1.46
Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control (2013) 1.46
Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res (2007) 1.45
Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden. Int J Cancer (2005) 1.45
Nondense mammographic area and risk of breast cancer. Breast Cancer Res (2011) 1.45
The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer (2006) 1.44
Prospective study of fertility concerns and preservation strategies in young women with breast cancer. J Clin Oncol (2014) 1.42
mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol (2011) 1.40
Mediterranean dietary pattern and mortality among young women: a cohort study in Sweden. Br J Nutr (2006) 1.40
A global assessment of the oesophageal adenocarcinoma epidemic. Gut (2012) 1.40
The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.39
[Colorectal cancer--a disease one doesn't talk about]. Tidsskr Nor Laegeforen (2007) 1.39
[Implementation of guidelines for PSA testing in general practice]. Tidsskr Nor Laegeforen (2014) 1.39
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer (2005) 1.38
LifeGene--a large prospective population-based study of global relevance. Eur J Epidemiol (2010) 1.38